Catalyst Wire Dossier Catalyst Wire Dossier

decitabine with GCLAM

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for decitabine with GCLAM, covering 2020-03-17 to 2020-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS [Phase 1, Phase 2]

See pricing